North Texas hospital officials say they have avoided canceling or delaying procedures after a crucial IV fluid manufacturing plant was damaged in Hurricane Helene.
Capsule contents were mixed with 15 mL of water, and tube flushes also occurred before and after drug administration. However, it was noted that tube occlusions developed in some children.
More U.S. investors are launching companies stateside that license technology from China, even as Congress moves to crack down on some Chinese companies through the BIOSECURE Act. Read more.
ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA,” the “Company,” or “we”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today ...
The "FDA Regulatory Compliance for Drug and Biotech Product Training Course" training has been added to ResearchAndMarkets.com's offering. This course will benefit professionals involved in working ...